Scanning and combinatorial library services – Save 20% with code TRY-BXPLIB-20

Categories

Category: Trends


October 4, 2021

Bringing Bright Minds Together for the Discovery on Target Conference

The Discovery on Target 2021 conference took place Sept 28-30 in Boston, bringing together several experts from across the US and globally to foster collaboration and share the latest advances in addressing key challenges in drug discovery. At this year’s…


August 25, 2021

A Tour of Key Milestones in Synthetic Biology

Synthetic biology has become so important and widely used that it’s easy to forget how young the field is. Much of the innovation that we rely on today took place in just the last two decades. Codex DNA was originally…


August 11, 2021

With mRNA Capping Technology, We’re Improving Synthesis Yields

If you’re working with synthetic mRNA, we have exciting news to share. In addition to releasing a new workflow earlier this year that makes it possible to synthesize mRNA form pooled oligos in a single overnight run on our BioXp™…


July 28, 2021

Happy RNA Day!

RNA Day is on Sunday, August 1st this year, and we welcome the international celebration of one of the most versatile biomolecules we have seen come to life. We have seen RNA play a key role in addressing the COVID-19…


June 16, 2021

RNA Society Conference Recap: Here’s What You Missed

Earlier this month, the Codex DNA team attended the RNA Society conference (all virtual in 2021) to discuss hot topics and relevant content for those responsible for leading their labs through the latest rounds of challenges and crossroads. A benefit…


June 2, 2021

PEGS 2021: Protein engineering in the spotlight

Earlier this month the Codex DNA team attended the PEGS Boston Summit, held this year as a virtual event. This important conference has been around for more than 15 years and is well known as a great resource to learn…


May 19, 2021

Countering emerging SARS-CoV-2 variants webinar recap: Four key takeaways

Last week, we had the opportunity to partner with Jesse Erasmus, Acting Assistant Professor of the University of Washington School of Medicine and Director of Virology at HDT Bio, presenting a webinar titled Development of a replicon RNA vaccine platform…


May 12, 2021

BCC Research podcast recap: Codex DNA on the future of synthetic biology

BCC sits down with Jason Lehmann, PhD, from Codex DNA, Inc. in San Diego to talk about Codex DNA’s mission of applying breakthroughs in synthetic biology automation solutions. BCC podcast host Clara Mouawad and Jason talk about Codex DNA’s recent…


April 25, 2021

Celebrating DNA Day

We’re celebrating two of the biggest discoveries in scientific history: The molecular structure of DNA and the complete mapping of all genes in the human genome The discovery of DNA’s double helix in 1953 and the completion of the Human…


April 14, 2021

Codex DNA partners with researchers to discover a new way to control citrus greening disease

The bacterial scourge of the citrus greening disease has affected citrus production worldwide, causing tree decline and a serious threat to Florida’s citrus industry. Citrus greening disease, or Huanglongbing (HLB), is caused by Candidotus liberibacter (CLass) and is spread by…


March 17, 2021

Great science: virtual AGBT and ABRF meetings highlight COVID-19 and more

The Codex DNA team loves to get its geek on. For the past year, we’ve missed in-person conferences, but virtual events still let us get up to speed on some of the latest advances in the scientific community. Most recently,…


March 10, 2021

Automated DNA synthesis in the spotlight at SLAS

The Codex DNA team was delighted to participate in this year’s SLAS annual conference, held by the Society for Laboratory Automation and Screening. While our favorite part of the virtual event was getting to interact with the many attendees who…


February 17, 2021

New resource: Biocompare ebook illustrates how life science tools are accelerating COVID-19 research

It can be tough to keep up on the latest COVID-19 news, but a new ebook from Biocompare is here to help. The ebook offers a nice array of articles focused on how novel tools are being used to accelerate…


February 10, 2021

Scientists use Codex DNA technology to discover fever-protective element in malaria parasite

Scientists have made a new discovery that could eventually lead to more effective treatment for malaria. In a series of experiments that included using the BioXp™ system, they determined that a key phospholipid and a related protein confer protection against…


January 27, 2021

AI-powered design tool and BioXp™ system accelerate metabolic engineering

The next industrial revolution will be biological. By turning cells into factories, synthetic biology changes how we make everything from plastic to food to medicine. But achieving those goals will require overcoming the limitations of DNA design. This is still…


January 20, 2021

Targeted mutagenesis could streamline antibody engineering

Monoclonal antibodies represent an important class of therapies for an ever-increasing number of diseases, infections, and health conditions. That’s why scientists around the world are working to improve the processes required to engineer new antibody candidates for therapeutic use. The…


January 13, 2021

Ready-made SARS-CoV-2 genomes from Codex DNA power development of vaccines, therapies, and diagnostics

Since the start of the COVID-19 pandemic, the Codex DNA team has been working hard to ensure that our customers have access to the tools they need to help in the fight against this public health scourge. We currently offer…


December 23, 2020

T cell engineering: How the BioXp™ system boosts productivity and decreases discovery time

At a recent Oxford Global NextGen Omics UK congress, our own Kirsty Maclean gave a presentation about how the BioXp™ system is powering advances in cell engineering. While she started with a high-level view of how synthetic biology applies to…


December 2, 2020

Cellibre scientists accelerate enzyme engineering with Codex DNA collaboration

One of the most popular applications of synthetic biology is to confer desired traits to an organism. Designing a range of possibilities and then testing each one for fitness, productivity, stability, or some other goal is critically important as the…


November 24, 2020

In pandemics, rapid DNA synthesis accelerates vaccine development

Back in 2013, I played a small role in response to what then seemed like the next potential pandemic — an outbreak of H7N9, an avian influenza virus. At the time, I was working with Novartis scientists, and we were…


November 18, 2020

Synthetic biology makes a difference in drug discovery

If you were there for the early days of synthetic biology, you probably remember it the way we do: a relatively small number of academic scientists toiling in labs to build key parts, like toggle switches, and tinkering with the…


November 11, 2020

Scientists develop nanobody treatments with the BioXp™ system

In the age of COVID-19, there has been a ton of scientific interest in nanobodies, or single-domain antibodies that can be used for finely targeted viral vaccines. It’s also been a hot topic among users of our BioXp™ system —…


October 28, 2020

Codex DNA celebrates Breast Cancer Awareness Month with great science

Breast cancer is now recognized as the most common malignancy worldwide among women, irrespective of age. Today’s standard of care and breast cancer management relies heavily on chemotherapy, hormone therapy, and targeted therapy. However, there is still much to be…


October 21, 2020

Highlights from the SynBioBeta 2020 Conference

The Codex DNA team really enjoyed attending this year’s virtual Global Synthetic Biology Conference hosted by SynBioBeta. If you missed the event, we’ve got you covered — here’s our take on highlights from the meeting. BioXp™ system in the spotlight…


October 6, 2020

Webinar: Rapid synthesis speeds immunotherapy development

For cancer patients with few other treatment options, the need for new targeted immunotherapies is genuinely a matter of life or death. So how to accelerate the development of new therapies? One key component is automated DNA synthesis. That was…


September 16, 2020

At Oxford conference, automated synthetic biology was in the spotlight

For BioXp™ system users, antibody drug discovery is one of the most popular applications. That’s why we were delighted to participate in the recent Oxford Global Biologics virtual conference, with a presentation from our own Kirsty Maclean, Director of Applications…


September 10, 2020

Biotech scientists use BioXp™ system to streamline antibody drug discovery

Several recent publications from the rockstar team at GigaGen illustrate how they are using the BioXp™ system to streamline antibody drug discovery workflows. It’s tough to overstate the importance of this area of research: monoclonal antibodies, antibody drug conjugates, and…


Contact us

The expertise of our scientists, engineers, and supporting teams is always available. Or call us: 858.228.4115

By clicking Submit, you agree that Codex DNA may use this information to contact you about our programs, products, or services. You may opt out at any time.

Your personal data is handled according to our privacy policy. In addition, if you are located within a distributor territory, you may be contacted directly by them. We never sell your data to anyone.